Key result
In salt-sensitive Dahl rats on a high-sodium diet, ET(A) receptor antagonist LU135252 partially reduced systolic blood pressure and normalized vascular reactivity.
Why the study?
Does ET(A) receptor antagonist LU135252 prevent vascular dysfunction and aortic hypertrophy in salt-sensitive Dahl rats on a high-sodium diet?
Does ET(A) receptor antagonist LU135252 prevent vascular dysfunction and aortic hypertrophy in salt-sensitive Dahl rats on a high-sodium diet?
ET(A) receptor antagonism prevents vascular dysfunction, aortic hypertrophy, and increased tissue ET-1 in a rat model of salt-sensitive hypertension.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for ET(A) antagonism in salt-sensitive hypertension; requires human trials before any clinical consideration.
Sodium plays an important role in the pathogenesis and therapy of hypertension, a major risk factor for cardiovascular disease. This study investigated the involvement of endothelin in vascular alterations in salt-induced Dahl hypertension. Salt-sensitive (DS) and salt-resistant (DR) Dahl rats were treated with a high-sodium diet (NaCl 4%) with or without ET(A) receptor antagonist LU135252 for two months, and effects of treatments on systolic blood pressure, vascular endothelin-1 (ET-1) protein content, aortic hypertrophy, and vascular reactivity of isolated aortic rings were studied. In DS rats, a high-sodium diet increased systolic pressure (190+/-4 versus 152+/-2 mm Hg, P<.05) and aortic ET-1 protein content (4.2-fold, P<.0001) and induced aortic hypertrophy as assessed by tissue weight (P<.0001). Sodium diet markedly reduced NO-mediated endothelium-dependent relaxations to acetylcholine (49+/-4% versus 81+/-4%, P<.0001) and contractions to ET-1 (92+/-7 versus 136+/-8% of KCl, P=.0011). ET-1 tissue levels were highly and inversely correlated with endothelium-dependent relaxations (r=0.931, P<.0001) and contractions to ET (r=0.77, P=.0007). LU135252 treatment reduced systolic blood pressure only in part (168+/-3 versus 190+/-4 mm Hg, P<.05) but normalized sodium-induced changes of vascular reactivity, tissue ET-1 protein content, and vascular structure (P<.001 versus sodium). None of these effects were observed in DR rats. These results suggest that ET-1 acts as a local mediator of vascular dysfunction and aortic hypertrophy in Dahl salt-induced hypertension. ET(A) receptor antagonism may have therapeutic potential for lowering vascular ET-1 content, improving endothelial function, and preventing structural changes in salt-sensitive hypertension.
No takes yet. Share an insight, caveat, or question.
Barton et al. (1998) studied Salt-sensitive hypertension. ET(A) receptor antagonist LU135252 vs. High-sodium diet without LU135252 was evaluated on Systolic blood pressure (p=<.05). In salt-sensitive Dahl rats on a high-sodium diet, ET(A) receptor antagonist LU135252 partially reduced systolic blood pressure and normalized vascular reactivity.
Synapse has enriched 10 related papers. Consider them for comparative context: